WIN 2012 Symposium The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside. The WIN 2012 Symposium provides an open forum for discussion between all stakeholdere in cancer biomarkers and therapeutics development and great networking opportunities for everyone involved in improving cancer patient care at the level of the individual patient.
The main theme of the 2012 symposium, Efficacy of biomarkers and personalised cancer therapeutics, will be elaborated in various plenary sessions, bringing togeteher a unique assembly of high-ranking experts from academia, industry and regulatory agencies wordwide as speakers and moderators.
|